how many americans are on a glp 1 Patrick Oben | in 9 now take GLP-1 medication. That's 11% of U.S. adults — up from just 3% in 2024. Nearly quadrupled in two years. But Nearly 12% of Americans have

Tracking metrics like fasting glucose, insulin sensitivity, and lipid profiles helps your provider understand whether your body is responding favorably to the GLP-1 therapy or showing signs of metabolic stress

PMCID: PMC4814192.10.1681/ASN.2015040339 [PMC free article: PMC4814192] [PubMed: 26283674] [CrossRef] 142

Some peptides have shown promising results in studies involving: However, there are important limitations to understand: This is why peptide therapy should be approached with realistic expectations and professional guidance rather than as a guaranteed solution

What it's made from: It's not extracted from animals or humans

Laschet, C., Dupuis, N